Various gut bacteria, including Lactobacillus plantarum, possess several enzymes that produce hydroxy fatty acids (FAs), oxo FAs, conjugated FAs, and partially saturated FAs from polyunsaturated FAs as secondary metabolites. Among these derivatives, we identified 10-oxo-cis-6,trans-11-octadecadienoic acid (gammaKetoC), a gamma-linolenic acid-derived enon FA, as the most effective immunomodulator, which inhibited the antigen-induced immunoactivation and the LPS-induced production of inflammatory cytokines. The treatment with gammaKetoC markedly increased the protein level of NRF2, a master transcription factor for antioxidant responses, and the mRNA level of Hmox1, a target gene of NRF2, in bone marrow-derived dendritic cells (BMDCs). Although gammaKetoC significantly suppressed the LPS-induced activation of control BMDCs, particularly the secretion of IL-12/23p40, the suppressive effects of gammaKetoC were reduced in Nrf2-/- BMDCs. GW9508, an agonist of GPR40/GPR120, inhibited the release of cytokines from LPS-stimulated BMDCs without activating the NRF2 pathway. We evaluated the role of NRF2 in the anti-inflammatory effects of gammaKetoC in a dextran sodium sulfate-induced colitis model. The oral administration of gammaKetoC significantly reduced body weight loss, improved stool scores, and attenuated atrophy of the colon, in wild-type C57BL/6J and Nrf2+/- (C57BL/6N) mice with colitis. In contrast, the pathology of colitis was deteriorated in Nrf2-/- mice even with the administration of gammaKetoC. Collectively, the present results demonstrated the involvement of the NRF2 pathway in gammaKetoC-mediated anti-inflammatory responses.